N-[[5-(TRIFLUOROMETHYL)-6-METHOXY-1-NAPHTHALENYL]THIOXOMETHYL]-N-METHYLGLYCINE (TOLRESTAT), A POTENT, ORALLY ACTIVE ALDOSE REDUCTASE INHIBITOR

被引：122

作者：

SESTANJ, K ^{[1
]}

BELLINI, F ^{[1
]}

FUNG, S ^{[1
]}

ABRAHAM, N ^{[1
]}

TREASURYWALA, A ^{[1
]}

HUMBER, L ^{[1
]}

SIMARDDUQUESNE, N ^{[1
]}

DVORNIK, D ^{[1
]}

机构：

[1] AYERST LABS RES INC,DEPT BIOCHEM,PRINCETON,NJ

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1984年 / 27卷 / 03期

关键词：

D O I：

10.1021/jm00369a003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：255 / 256

页数：2

共 17 条

[1]

BOULANGER M, 1981, DIABETOLOGIA, V21, P253

[2]

CAYEN MN, 1978, PHARMACOLOGIST, V20, P214

[3]

CHYLACK LT, 1979, OPHTHALMOLOGY, V86, P1579

[4] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT [J].

CULEBRAS, A ;

ALIO, J ;

HERRERA, JL ;

LOPEZFRAILE, IP .

ARCHIVES OF NEUROLOGY, 1981, 38 (02) :133-134

[5] POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR [J].

DVORNIK, D ;

SIMARDDU.N ;

KRAMI, M ;

SESTANJ, K ;

GABBAY, KH ;

KINOSHITA, JH ;

VARMA, SD ;

MEROLA, LO .

SCIENCE, 1973, 182 (4117) :1146-1148

[6] EFFECTS OF ALDOSE REDUCTASE INHIBITOR TREATMENT IN DIABETIC POLYNEUROPATHY - A CLINICAL AND NEUROPHYSIOLOGICAL STUDY [J].

FAGIUS, J ;

JAMESON, S .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (11) :991-1001

[7]

FAGIUS J, 1980, Acta Neurologica Scandinavica Supplementum, V62, P125

[8] SYNTHESES OF 1-TRIFLUOROMETHYL-2-NAPHTHALENOLS VIA A NOVEL CONSTRUCTION OF THE NAPHTHALENE NUCLEUS [J].

FUNG, S ;

ABRAHAM, NA ;

BELLINI, F ;

SESTANJ, K .

CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1983, 61 (02) :368-371

[9] ALDOSE REDUCTASE INHIBITION - STUDIES WITH ALRESTATIN [J].

GABBAY, KH ;

SPACK, N ;

LOO, S ;

HIRSCH, HJ ;

ACKIL, AA .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (04) :471-476

[10]

GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609

← 1 2 →